Reproductive phenotypes of the progesterone receptor null mutant mouse

Journal of Steroid Biochemistry and Molecular Biology

Volumn 56, Issue 1-6, 1996, Pages 67-77

  Lydon, John P ^a   DeMayo, Francesco J ^a   Conneely, Orla M ^a   O'Malley, Bert W ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR;

ANIMAL MODEL; BREAST; CONFERENCE PAPER; DEVELOPMENT; FEMALE; MALE; MOUSE; MUTANT; NONHUMAN; OVULATION; PHENOTYPE; REPRODUCTION; SEXUAL BEHAVIOR; SIGNAL TRANSDUCTION; ANIMAL; BODY POSTURE; BONE; CONGENITAL MALFORMATION; ENDOMETRITIS; FEMALE INFERTILITY; FERTILITY; GENETICS; HYPERPLASIA; IMMUNOMODULATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; PREGNANCY; REVIEW; SEXUAL DYSFUNCTION; UDDER; UTERUS;

ANIMALS; BONE AND BONES; ENDOMETRITIS; FEMALE; FERTILITY; HYPERPLASIA; INFERTILITY, FEMALE; MALE; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; MICE, MUTANT STRAINS; NEUROIMMUNOMODULATION; OVULATION; PHENOTYPE; POSTURE; PREGNANCY; RECEPTORS, PROGESTERONE; SEXUAL BEHAVIOR, ANIMAL; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; UTERUS;

EID: 0029664535     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00254-5     Document Type: Conference Paper

References (78)

1. Baulieu E. E.: Contragestion and other clinical applications of RU486, an antiprogesterone at the receptor. Science 245 (1989) 1351-1357.
2. Clarke C. L. and Sutherland R. L.: Progestin regulation of cellular proliferation. Endocrine Rev. 11 (1990) 266-300.
3. Schrader W. T. and O'Malley B. W.: Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits. J. biol. Chem. 247 (1972) 51-59.
4. Conneely O. M., Maxwell B. L., Toft D. O., Schrader W. T. and O'Malley B. W.: The A and B forms of the chicken progesterone receptor arise by alternate initiation of translation of a unique mRNA. Biochem. Biophys. Res. Commun. 149 (1987) 493-501.
5. Kastner P., Krust A., Turcotte B., Strupp U., Tora L., Gronemeyer H. and Chambon P.: Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9 (1990) 1603-1614.
6. Conneely O. M., Sullivan W. P., Toft D. O., Birnbaumer M., Cook R. G., Maxwell B. L., Zarucki Schulz T., Greene G. L., Schrader W. T. and O'Malley B. W.: Molecular cloning of the chicken progesterone receptor. Science 233 (1986) 767-770.
7. Evans R. M.: The steroid and thyroid hormone receptor superfamily. Science 240 (1988) 889-895.
8. Tsai M.-J. and O'Malley B. W.: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. A. Rev. Biochem. 63 (1994) 451-486.
9. Carson-Jurica M. A., Schrader W. T. and O'Malley B. W.: Steroid receptor family: structure and functions. Endocrine Rev. 11 (1990) 201-220.
10. Lydon J. P., DeMayo F. C. A. J., Funk C. R., Mani S. K., Hughes A. R., Montgomery Jr. C. A., Shyamala G., Conneely O. M. and O'Malley B. W.: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev. 9 (1995) 2266-2278.
11. Mansour S. L., Thomas K. R. and Capecchi M. R.: Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336 (1988) 348-352.
12. Hou Q. and Gorski J.: Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 9460-9464.
13. Lubahn D. B., Moyer J. S., Golding T. S., Couse J. F., Korach K. S. and Smithies O.: Alteration of reproductive function but not prenatal sexual devlopment after insertional disruption of the mouse estrogen receptor gene. Proc. Natn. Acad. Sci. U.S.A. 90 (1993) 11,162-11,166.
14. Yang J., Serres C., Philibert D., Robel P., Baulieu E.-E. and Jouannet P.: Progesterone and RU486: opposing effects on human sperm. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 529-533.
15. Baldi E., Krausz C., Luconi M., Bonaccorsi L., Maggi M. and Forti G.: Actions of progesterone on human sperm: a model of non-genomic effects of steroids. J. Steroid Biochem. Molec. Biol. 53 (1995) 199-203.
16. Yoshimura Y., Hosoi Y., Bongiovanni A. M., Santulli R., Arlas S. J. and Wallach E. E.: Are ovarian steroids required for ovum maturation and fertilization? Effects of cyanoketone on the in vitro perfused rabbit ovary. Endocrinology 120 (1987) 2555-2561.
17. Tanaka N., Espey L. L., Stacy S. and Okamura H.: Epostane and indomethacin actions on ovarian kallikrein and plaominogen activator activities during ovulation in the gonadotropin-primed immature rat. Biol. Reprod. 46 (1992) 665-670.
18. Loutradis D., Bletsa R., Aravantinos L., Kallianidis K., Michalas S. and Psychoyos A.: Preovulatory effects of the progesterone antagonist mifepristone (RU486) in mice. Hum. Reprod. 6 (1991) 1238-1240.
19. Mori T., Suzuki A., Nishimura T. and Kambegawa A.: Inhibition of ovulation in immature rats by antiprogesterone antiserum. J. Endocr. 73 (1977) 185-186.
20. Natraj V. and Richards J. S.: Hormonal regulation, localization, and functional activity of the progesterone receptor in granulosa cells of rat preovulatory follicles. Endocrinology 134 (1993) 709-718.
21. Park-Sarge O.-K. and Mayo K. E.: Regulation of progesterone receptor gene by gonadotropins and cyclic adenosine 3′,5′-monophosphate in rat granulosa cells. Endocrinology 134 (1994) 709-718.
22. Iwamasa J., Shibata S., Tanaka N., Matsuura K. and Okamura H.: The relationship between ovarian progesterone and proteolytic enzyme activity during ovulation in the gonadotropintreated immature rat. Biol. Reprod. 46 (1992) 309-313.
23. Chandrasekher Y. A., Melner M. H., Nagalla S. R. and Stouffer R. L.: Progesterone receptor, but not estradiol receptor, messenger ribonucleic acid is expressed in luteinizing granulosa cells and the corpus luteum of rhesus monkeys. Endocrinology 135 (1994) 307-314.
24. Jordan V. C. and Dix C. J.: Effect of estradiol benzoate, tamoxifen and monohydroxytamoxifen on immature rat uterine progesterone receptor synthesis and endometrial cell division. J. Steroid Biochem. 11 (1979) 285-291.
25. Martin L.: Early cellular changes and circular muscle contraction associated with the induction of decidualization by intrauterine oil in mice. J. Cell Biochem. 55 (1979) 135-139.
26. Ledford B. E., Rankin J. C., Markwald R. R. and Bagget B.: Biochemical and morphological changes following artificially stimulated decidualization in the mouse uterus. Biol. Reprod. 15 (1979) 529-535.
27. Martin L., Finn C. A. and Trinder G.: Hypertrophy and hyperplasia in the mouse uterus after estrogen treatment: an autoradiographic study. J. Endocr. 56 (1973) 133-144.
28. Quarmby V. E. and Korach K. S.: The influence of 17β-estradiol on patterns of cell division in the uterus. Endocrinology 114 (1984) 694-702.
29. Cheung L., Kelly R. W., Thong K. J., Hume R. and Baird D. T.: The effect of mifepristone (RU486) on the immunohistochemical distribution of prostaglandin E and its metabolite in decidual and chorionic tissue in early pregnancy. J. Clin. Endocr. Metab. 77 (1993) 873-877.
30. Ito A., Imada K., Takashi S., Kubo T., Matsushima K. and Mori Y.: Suppression of interleukin 8 production by progesterone in rabbit uterine cervix. Biochem. J. 301 (1994) 183-186.
31. Bresciani F.: Topography of DNA synthesis in the mammary gland of the C3H mouse and its control by ovarian hormones: an autoradiographic study. Cell Tissue Kinet. 1 (1968) 51-63.
32. Shyamala G. and Ferenczy A.: Mammary fat pad may be a potential site for initiation of estrogen action in normal mouse mammary glands. Endocrinology 115 (1984) 1078-1081.
33. Shyamala G.: Endocrine and other influences in the normal development of the breast. In Fundamental Problems in Breast Cancer (Edited by A. H. G. Paterson and A. W. Lees). Martinus Nijhoff, Boston, MA (1987) pp. 127-137.
34. Haslam S. Z.: Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology 122 (1988) 464-470.
35. Imagawa W., Tomooka Y., Hamamoto S. and Nandi S.: Stimulation of mammary epithelial cell growth in vitro and interaction of epidermal growth factor and mammogenic hormones. Endocrinology 116 (1985) 1514-1524.
36. Horwitz K. B.: The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocrine Rev. 13 (1992) 146-163.
37. Welsch C. W.: Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 45 (1985) 3415-3443.
38. Robinson S. P. and Jordan V. C.: Reversal of the antitumor effects of tamoxifen by progesterone in the 7,12-dimethyl benzanthracene-induced rat mammary carcinoma model. Cancer Res. 47 (1987) 5386-5390.
39. Groyer A., Schweizer-Groyer G., Cadepond F., Mariller M. and Baulieu E. E.: Anti-glucocorticosteroid effects suggest why steroid hormone is required for receptor to bind DNA in vivo but not in vitro. Nature 328 (1987) 624-626.
40. Mani S. K., Blaustein J. D., Allen J. M., Law S. W., O'Malley B. W. and Clark J. H.: Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor. Endocrinology 135 (1994) 1409-1414.
41. Ogawa S., Olazabal V. E., Parhar I. S. and Pfaff D.: Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat. J. Neurosci. 14 (1994) 1766-1774.
42. Rainbow T., Parsons B. and McEwen B. S.: Sex differences in rat brain oestrogen and progestin receptors. Nature 300 (1982) 648-649.
43. Arnold A. P. and Breedlove S. M.: Organizational and activational effects of sex steroids on brain and behavior: a reanalysis. Hormones Behav. 19 (1985) 469-498.
44. Frankfurt M., Gould E., Woolley C. and McEwen B. S.: Gonadal steroids modify dendritic spine density in ventromedial hypothalamic neurons: a Golgi study in the adult rat. Neuroendocrinology 51 (1990) 530-535.
45. McEwen B. S.: Genomic regulation of sexual behavior. J. Steroid Biochem. 30 (1988) 179-183.
46. Parsons B., Rainbow T. C., Maclusky N. J. and McEwen B. S.: Progestin receptor levels in rat hypothalamic and limbic nuclei. J. Neurosci. 2 (1982) 1446-1452.
47. Gould E., Woolley C., Frankfurt M. and McEwen B. S.: Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J. Neurosci. 10 (1990) 1286-1291.
48. Olton D. D. S.: Memory functions and the hippocampus. In Neurobiology of the Hippocampus (Edited by W. Seifert). Academic Press, London (1983) pp. 335-373.
49. Williams C. L. and Meck W. H.: The organizational effects of gonadal steroids on sexually dimorphic spatial ability. Psychoneuroendocrinology 16 (1991) 155-176.
50. Roof R. L., Duvdevani R., Braswell L. and Stein D. G.: Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 129 (1994) 64-69.
51. Akwa Y., Young J., Kaggadj K., Sancho M. J., Zucman D., Vourc'H C., Jung-Testas I., Hu Z. Y., LeGoascogne C., Jo D. H., Corpechot C., Simon P., Baulieu E. E. and Robel P.: Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain. J. Steroid Biochem. Molec. Biol. 40 (1991) 71-81.
52. LeGoascogne C., Robel P., Gouezou M. and Waterman M.: Neurosteroids: cytochrome p-450scc in rat brain. Science 237 (1987) 1212-1215.
53. Koenig H. L., Schumacher M., Ferzaz B., DoThi A. N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y. and Baulieu E. E.: Progesterone synthesis and myelin formation by Schwann cells. Science 268 (1995) 1500-1503.
54. Paul S. M. and Purdy R. H.: Neuroactive steroids. FASEB J. 6 (1992) 2311-2322.
55. Grossman C. J.: Interactions between the gonadal steroids and the immune system. Science 227 (1985) 257-261.
56. Morell V.: Zeroing in on how hormones affect the immune response. Science 269 (1995) 773-775.
57. Szekeres-Bartho J., Kilar F., Falkay G., Csernus V., Torok A. and Pacsa A. S.: The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: 1. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am. J. Reprod. Immunol. Microbiol. 9 (1985) 15-18.
58. Szekeres-Bartho J., Autran B., Debre P., Andreu G., Denver L. and Chaouat G.: Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol. 122 (1989) 281-294.
59. Szekeres-Bartho J., Kinsky R. and Chaouat G.: The effect of a progesterone-induced immunologic blocking factor on NK-mediated resorption. Am. J. Reprod. Immun. Microbiol. 24 (1990) 105-107.
60. Bruner K. L., Rodgers W. H., Gold L. I., Korc M., Hargrove J. T., Marrisian L. M. and Osteen K. G.: Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc. Natn. Acad. Sci. U.S.A. 92 (1995) 7362-7366.
61. Hutchinson T., Polansky S. and Feinstein A.: Post-menopausal oestrogens protect against fractures of hip and distal radius: a case-control study. Lancet 2 (1979) 705-709.
62. Bain S. D., Jensen E., Celino D. L., Bailey M. C., Lantry M. M. and Edwards M. W.: High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse. J. Bone Miner. Res. 8 (1993) 219-229.
63. Prior J. C.: Progesterone as a bone-trophic hormone. Endocrine Rev. 11 (1990) 386-398.
64. Vegeto E., Shahbaz M. M., Wen D. X., Goldman M. E., O'Malley B. W. and McDonnell D. P.: Human progesterone receptor A form is a cell and promoter specific repressor of human progesterone receptor B function. Molec. Endocr. 7 (1993) 1244-1255.
65. Kazmi S. M. I., Visconti V., Plante R. K., Ishaque A. and Lau C.: Differential regulation of human progesterone receptor A and B form-mediated trans-activation by phosphorylation. Endocrinology 144 (1993) 1230-1238.
66. Tung L., Mohamed M. K., Hoeffler J. P., Takimoto G. S. and Horwitz K. B.: Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Molec. Endocr. 7 (1993) 1256-1265.
67. Sartorius C. A., Tung L., Takimoto G. S. and Horwitz K. B.: Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP. J. Biol. Chem. 268 (1993) 9262-9266.
68. Chalbos D. and Galtier F.: Differential effect of forms A and B of human progesterone receptor on estradiol-dependent transcription. J. Biol. Chem. 269 (1994) 23,007-23,012.
69. McDonnell D. P. and Goldman M. E.: RU486 exerts antiestrogenic activities through a novel progesterone receptor. A formmediated mechanism. J. Biol. Chem. 269 (1994) 11,945-11,949.
70. Sartorius C. A., Groshong S. D., Miller L. A., Powell R. L., Tung L., Takimoto G. S. and Horwitz K. B.: New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res. 54 (1994) 3868-3877.
71. McDonnell D. P., Shahbaz M. M., Vegeto E. and Goldman M. E.: J. Steroid Biochem. Molec. Biol. 48 (1994) 425-432.
72. Horwitz K. B., Tung L. and Takimoto G. S.: Novel mechanisms of antiprogestin action. J. Steroid Biochem. Molec. Biol. 53 (1995) 9-17.
73. Hasty P., Ramirez-Solis R., Kumlauf R. and Bradley A.: Introduction of a subtle mutation into the Hox2.6 locus in embryonic stem cells. Nature 350 (1991) 243-246.
74. Wu H., Liu X. and Jaenisch R.: Double replacement: strategy for efficient introduction of mutations into the murine Co/1a-1 gene by homologous recombination in embryonic stem cells. Proc. Natn. Acad. Sci. U.S.A. 91 (1994) 2819-2823.
75. Barinaga M.: Knockout mice: Round Two. Science 265 (1994) 26-27.
76. Gu H., Marth J. D., Orban P. C., Mossmann H. and Rajewski K.: Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 265 (1994) 103-106.
77. Hanks M., Wurst W., Anson-Cartwright L., Auerbach A. B. and Joyner A. L.: Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269 (1995) 679-682.
78. Kuhn R., Schwenk F., Aguet M. and Rajewsky K.: Inducible gene targeting in mice. Science 269 (1995) 1427-1429.